US 11033612
Human-enzyme mediated depletion of homocysteine for treating patients with hyperhomocysteinemia and homocystinuria
granted A61KA61K31/198A61K31/4415
Quick answer
US patent 11033612 (Human-enzyme mediated depletion of homocysteine for treating patients with hyperhomocysteinemia and homocystinuria) held by The Board of Regents of the University of Texas System expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Jun 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 34
- CPC classes
- A61K, A61K31/198, A61K31/4415, A61K38/51, A61K47/60